HC Deb 26 June 2001 vol 370 cc504-6
8. Mr. Alan Simpson (Nottingham, South)

What treatment is available within the NHS for macular degeneration. [488]

The Parliamentary Under-Secretary of State for Health (Yvette Cooper)

There are two kinds of age-related macular degeneration. Dry age-related macular degeneration accounts for 90 per cent. of cases and has no currently available treatment. Wet age-related macular degeneration can be treated with laser coagulation and photodynamic therapy on the NHS.

Mr. Simpson

I know that the Minister will share my concern about the increasing numbers of older people who suffer from macular degeneration—bleeding at the back of the eye that destroys all central vision and results in near blindness. I know that she is also aware that the Queen's medical centre in my constituency is one of four centres of excellence which are offering treatments in the United Kingdom that had previously been available only in other parts of Europe.

I am sure that the Minister will be delighted to know that those treatments take up no more than half an hour of NHS time, but I am sure that she will share my concern to discover that patients in Nottingham are being told that they cannot have access to such treatment under the NHS unless they can fork out £1,000 a time for it. Will she look into the charging process that makes those treatments available in our own funded programmes, and give the House some assurance about when we shall be able to guarantee that those treatments will be available on the basis of need, not wealth?

Yvette Cooper

I can assure my hon. Friend that I will look into the cases that he describes. I am not aware of the details that he is talking about. I know, however, that we have asked the National Institute for Clinical Excellence to examine one of the proposed treatments, visudyne, which is being trialled in many areas across the NHS, to assess its clinical and cost effectiveness, so that we can follow set recommendations throughout the NHS instead of different recommendations being followed in different areas.

Mr. David Tredinnick (Bosworth)

May I correct the Minister and say that macular degeneration can be treated by using homeopathic remedies, by herbal remedies and by using acupuncture? Is not it very regrettable that, since the introduction of primary care groups in the national health service, the number of complementary therapies available in the health service has decreased? Will the Government look into that urgently? Was the Minister aware that last week was homeopathic awareness week, which of course was very important?

Yvette Cooper

I certainly congratulate the hon. Gentleman on finding an opportunity to raise complementary and alternative medicine in Health questions—the clock was ticking and I wondered when he would find the opportunity to do so. He has taken the opportunity to inform the House of the fact that last week was homeopathic awareness week.

I am interested to hear what the hon. Gentleman says about the possible impact of complementary and alternative medicine on treating age-related macular degeneration. He is aware that we have provided extensive information to primary care groups to promote their awareness of the impact that complementary and alternative medicine can have. The choice of treatments is obviously a decision for primary care groups and trusts to take, but we are keen to ensure that they have full information about the benefits of complementary and alternative medicine so that they can take informed decisions in the interests of their patients.